ADmit Therapeutics

Impact sector

  • Health

Industrial sector

  • Biotech


Ship2B Investment

  • Equity4Good
  • Investment network


Admit Therapeutics is a startup that focuses on the development and commercialization of a new technology for Alzheimer’s early detection. Their objective is to implement their test into clinical practice so patients can be referred to curative therapies as quickly as possible, thus improving their quality of life and their families.



Join the Impact Community!